Regulation of nitic oxide production by salicylates and tenidap in human OA-affected cartilage, rat chondrosarcomas and bovine chondrocytes  by Attur, Mukundan G. et al.
Osteoarthritis and Cartilage (1998) 6, 269–277
7 1998 Osteoarthritis Research Society 1063–4584/98/040269 + 09 $12.00/0
Article No. oc980120
Regulation of nitric oxide production by salicylates and tenidap in
human OA-affected cartilage, rat chondrosarcomas
and bovine chondrocytes
By Mukundan G. Attur*, Rajesh Patel*, Paul E. DiCesare†, German C. Steiner‡,
Steven B. Abramson and Ashok R. Amin*‡§
*Department of Rheumatology, Hospital for Joint Diseases, New York; †Department of Orthopaedics,
Hospital for Joint Diseases, New York; ‡Department of Pathology, Kaplan Cancer Center, New York
University Medical Center, New York; §Department of Medicine, New York University Medical Center,
New York, U.S.A.
Summary
Objective: To examine the effects of non-steroidal anti-inflammatory drugs (NSAIDS) on nitric oxide (NO) and
prostaglandin E2 (PGE2) production in chondrocytes from three different species.
Methods: We have estimated NO production by Griess method, and PGE2 by RIA from the supernatants of articular
cartilage obtained from osteoarthritis joints (OA-affected cartilage), rat chondrosarcomas (in ex vivo conditions) and
bovine chondrocytes (stimulated with cytokines + endotoxin in in vitro conditions) in the presence or absence of
aspirin, indomethacin, sodium salicylate, tenidap and glucocorticoids.
Results: NO, which was spontaneously released in ex vivo conditions by OA-affected cartilage and rat
chondrosarcomas (maintained in vivo), was susceptible to inhibition by pharmacologically relevant concentrations of
aspirin, sodium salicylate and tenidap, but not to concentrations of indomethacin or glucocorticoids that significantly
inhibited PGE2 production under the same conditions. Similarly, the production of NO by bovine chondrocytes grown
in monolayer cultures that had been stimulated with cytokines + endotoxins (in vitro) to release both NO and PGE2
(at 48–72 h post stimulation), were inhibited by aspirin, sodium salicylate and tenidap, but not by indomethacin or
glucocorticoids at concentrations sufficient to inhibit PGE2 production. Inhibition of NO in the cytokines + endotoxin
stimulated bovine chondrocytes (like the human OA-affected cartilage) augmented PGE2 production.
Conclusion: These experiments demonstrate that NO production by chondrocytes across species show a similar
profile of susceptibility to inhibition by selected anti-inflammatory drugs. The insensitivity of NO production to
glucocorticoids is an important characteristic of these cells that merits further investigation.
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Introduction
Inducible nitric oxide synthase (iNOS) plays an
important role in inflammation, host-defense
responses, and tissue repair [1]. Nitric oxide (NO)
formation is increased during inflammation (e.g.,
rheumatoid arthritis, ulcerative colitis or Crohn’s
disease) and several classic inflammatory symp-
toms such as erythema and vascular leakiness [2].
The role of NO has been well demonstrated in
various animal models of arthritis [3, 4]. The
increased production of NO characteristic of the
rodent models of arthritis has been observed in
human studies. Mean serum nitrite concentrations
in individuals affected by rheumatoid arthritis
(RA) and osteoarthritis (OA) are significantly
higher than those observed in normal controls [5].
In both disease groups, nitrite concentrations were
significantly higher in synovial fluid than serum,
implying synthesis of NO within diarthrodial
joint(s) where both synoviocytes and chondrocytes
have been implicated as sites of increased NO
production [6, 7]. Previous studies have also shown
that OA/RA-affected cartilage in ex vivo conditions
release NO in sufficient quantities to cause
cartilage dysfunction [6, 7]. Recent studies have
suggested that superficial and deep human and
bovine articular chondrocytes show differential
production of NO [8, 9]. Excessive concentrations
of nitric oxide exert profound effects on chondro-
cyte functions, including: down regulation of
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collagen synthesis [10], inhibition of actin polym-
erization [11], down regulation of interleukin
IL-1RA expression [12] and induction of apoptosis
[13]. Furthermore, two groups have independently
presented evidence to suggest that NO induces the
synthesis of matrix metalloproteases by monolayer
cultures of articular chondrocytes [14, 15]. These
manifestations induced by NO, collectively may be
a possible mechanism of pathological neovas-
culization in arthritis.
Although non-steroidal anti-inflammatory drugs
(NSAIDS) clearly inhibit the synthesis and release
of prostaglandins, these actions are not sufficient
to explain all the anti-inflammatory effects of
NSAIDS. For example, NSAIDS also inhibit
activation of neutrophils, which release inflamma-
tory mediators other than prostaglandins [16].
We have recently observed that several anti-
inflammatory drugs, (namely salicylates, glucocor-
ticoids and tetracyclines) inhibit iNOS expression
in murine macrophages stimulated with lipo-
polysaccharides (LPS) [17]. In the present study,
we investigated the capacity of NSAIDS to inhibit
spontaneous release of NO and prostaglandin E2
(PGE2) by OA-affected cartilage and rat chon-
drosarcoma cells (in ex vivo conditions). We also
investigated the action of NSAIDS on in vitro
cytokine [IL-1b and tumor necrosis factor
(TNFa)] + endotoxin stimulated bovine chondro-
cytes producing NO and PGE2. We report that
aspirin, sodium salicylate and tenidap, but not
indomethacin, inhibit NO production in human
OA-affected cartilage, chondrosarcomas, and
bovine chondrocytes. The failure of glucocorticoid
to inhibit NO production in human chondrocytes,
rat chondrosarcomas and bovine chondrocytes is
distinct from the previous report of its effects on
murine macrophages.
Methods
reagents and cell lines
RPMI-1640 and Ham’s F-12 were purchased from
Mediatech Inc. (Hernden, VA, U.S.A.). The
endotoxin level in this media was Q 0.01 ng/ml.
LPS, NSAIDS and steroids were obtained from
Sigma (St. Louis, MO, U.S.A.) Cytokines were
purchased from Fischer Scientific (Pittsburgh, PA,
U.S.A.). Tenidap was kindly provided by Pfizer,
Inc. (Groton, CT, U.S.A.).
procurement of human cartilage
Cartilage slices were taken from the knees
(tibial plateau and femoral condyle) of patients
with the diagnosis of advanced OA (age 50–70
years) who were undergoing knee replacement
surgery.
procurement of bovine chondrocytes
The bovine cartilage was obtained from young
calfs. Isolation of bovine chondrocytes from hoofs
was carried out by standard methods [18, 19] with
minor modifications. Briefly, normal bovine carti-
lage was washed in RPMI-1640 and cut into small
pieces and digested with enzymes. Cartilage pieces
were incubated with trypsin (0.25%) in RPMI-1640
(Gibco BRL, Gaithersburg, MD, U.S.A.) for 30 min
at 37° C before they were washed and re-incubated
in hyaluronidase (0.2%) and collagenase (0.2%),
dissolved in RPMI-1640 containing 5% fetal bovine
serum (FBS) for 16 h at 37 ° C with continuous
agitation (100 rpm). The cells were passed through
75 mm nylon mesh and washed twice with PBS to
remove cell debris. The released cells were
suspended in RPMI 1640 + 10% FBS + antibiotics
and plated in a 24-well plate (Becton Dickinson,
Lincoln Park, NJ, U.S.A.) at a density of 5 · 105
cells/2.0 cm2. After 48 h, the medium was changed
and the cells were preincubated in fresh media
with various modulators (NSAIDS) for 2 h before
stimulating them with IL-1b (1 ng/ml) + TNFa
(100 U/ml) and LPS 100 mg/ml) and analyzed for NO
and PGE2 levels at 48–72 h of post stimulation.
Ethanol was used as a carrier for the NSAIDS and
carrier concentration was maintained ( Q 0.01%
v/v) in the cultures. Equivalent amount of ethanol
was also added to the control cultures. Culture
media were assayed for NO and PGE2 at different
time intervals.
isolation and maintenance of rat
chondrosarcoma cells
A Swarm rat chondrosarcoma cell line was
maintained in Sprague–Dawley rats as previously
described [20]. Briefly, 100 g Sprague–Dawley male
rats were subcutaneously implanted with the
Swarm rat chondrosarcoma. The Swarm rat
chondrosarcoma is a well-differentiated malignant
tumor that resembles a well-differentiated human
chondrosarcoma [21]. After 3 weeks, the animals
were sacrificed by CO2 asphyxiation and tumor
harvested using sterile technique. The solid tumor
was minced with scissors, centrifuged, and di-
gested with 0.5 mg/ml hyaluronidase (Sigma, MO,
U.S.A.) for 10 min followed by 0.2% (w/v) collagen-
ase (Worthington Biochem. Co., NJ, U.S.A.) for 2 h
in Hams-F12 media (Life Technologies Inc., Grand
Island, NY, U.S.A.), 10 mm Hepes, pH 7.4,
Osteoarthritis and Cartilage Vol. 6 No. 4 271
containing 50 mg/ml gentamicin in a Spinner
culture flask at 37° C. The cells were filtered
(150 mm nylon mesh) to remove remaining large
cellular debris.
Cells were washed and resuspended in Hams-F12
media, 50 mg/ml gentamicin, 10 mm Hepes, pH 7.4,
containing 1% fetal calf serum (FCS) at a final
concentration of 5 · 105/ml. The cells were then
transferred to a 24-well cell culture plates (5 · 105
cells/well) and allowed to attach for 24 h. After
24 h, the medium was changed and NSAIDS were
added. Ethanol was used as a carrier.
human oa-explant assay
Total knee articular cartilage from tibial
plateau and femoral condyle were harvested from
OA-affected patients. The cartilage was mixed and
cut into 3-mm discs and four to six discs were
placed in triplicate or quadruplicate, in a 24-well
plate in 2.0 ml Ham’s F-12 medium supplemented
with 0.2% endotoxin free human albumin, 10 mm
Hepes at pH 7.4 and antibiotics in the presence of
various modulators, as previously described [6, 22].
The NSAIDS, tenidap, and glucocorticoids were
used at pharmacologically relevant concentrations
in ethanol [ Q 0.01% (v/v) final concentration] as
carrier. Equivalent amount of ethanol was added
in all cultures.
determination of pge2 and nitrite
PGE2 was determined in the culture supernatant
using a radio-immunoassay (RIA) kit (Sigma, MO,
U.S.A.) according to the manufacturer’s instruc-
tions. The detection limit was 1.0 pg/ml. NO
production was measured by estimating the stable
NO metabolite, nitrite, in conditioned medium, by
a modified Griess reaction [23]. The values were
expressed as micromolar nitrite or ng/ml PGE2
released per 100 mg wet weight of cartilage and
5 · 105 of chondrocytes.
statistical analysis
The data represents a minimum of one of the two
experiments performed from separate OA-affected
cartilage samples. All experiments using cartilage
slices, rat chondrosarcoma cells or bovine chon-
drocytes were performed in triplicate or quadrupli-
cate for each parameter studied. Data are
expressed as mean 2 s.d. and statistical analysis
was performed using GraphPAD Software (v 1.14).
The t test or non parametric (Mann–Whitney or
Wilcoxon) test were performed for all the
experiments.
Results
We have recently reported that aspirin
and sodium salicylate, but not indomethacin
could inhibit NO production in murine macro-
phages in a PGE2/COX-2 independent fashion [17].
We have now extended those studies to three
chondrocyte systems, each of different species.
These include human OA-affected cartilage,
Swarm rat chondrosarcoma cells and bovine
chondrocytes.
In an effort to elucidate the effect of NSAIDS on
NOS expression and function in cartilage and
chondrocytes, we have selected four known
NSAIDs: an acetylated salicylate (aspirin, an
effective inhibitor of COX-2 at the concentrations
studied); a non-acetylated salicylate (sodium
salicylate, a less effective inhibitor of COX-2)
indomethacin (a potent inhibitor of COX-2) and
tenidap (an anti-inflammatory drug that inhibits
COX-2 as well as IL-1b production) [24]. We tested
the hypothesis that NSAIDS, which inhibited NO
production in murine macrophages also modulates
NOS in cartilage and chondrocytes in a COX-2
independent manner across species. Salicylates,
indomethacin and tenidap, which reach thera-
peutic concentrations in plasma of 1–3 mm,
5–20 mm, and 30 mm, respectively [25] were tested for
their capacity to inhibit NO production at the
clinically relevant concentrations.
For the present study we selected three model
systems for the study of chondrocytes: (a) human
OA-affected cartilage, (b) rat chondrosarcoma cells
and (c) bovine chondrocytes. In the OA-affected
cartilage and rat chondrosarcoma cells, the NO
(induced in vivo) was spontaneously released in ex
vivo conditions [6, 26]. The NOS isoforms expressed
in OA-affected cartilage and rat chondrosarcoma
cells are different in view of the 150 kDa OA-NOS
in OA-affected cartilage [6] and 133 kDa iNOS in
the rat chondrosarcoma cells [26]. The third model
system was bovine chondrocytes, which when
grown in monolayer culture, produces NO (and
express a 133 kDa iNOS) upon in vitro stimulation
with cytokines + endotoxin (Fig. 1).
effect of nsaids on no production in
oa-affected cartilage under ex vivo
conditions
Human OA-affected cartilage explants in ex vivo
conditions were supplemented with aspirin,
sodium salicylate and indomethacin as shown in
Tables I and II. The spontaneous release of NO was
monitored at different time intervals. As expected,
time dependent spontaneous release of NO in
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Fig. 1. Western blot analysis of iNOS from murine
macrophages and bovine chondrocytes. Murine macro-
phages (RAW 264.7 cells) were stimulated with 1 mg/ml
of LPS for 24 h and cells were harvested. Bovine
chondrocytes were seeded for 48 h. After 48 h the
adherent cells were stimulated with IL-1b (1 ng/ml) +
TNFa (100 U/ml) and LPS (100 mg/ml) for 48 h before the
cells were harvested. The cell free extracts were
prepared as previously described [25]. One hundred
micrograms of protein was loaded on the sodium dodecyl
sulfate—polyacrylamide gel (SDS-PAGE) and western
blotted using an anti-iNOS monoclonal antibody from
Transduction Labs (Lexington, KY, U.S.A.) which cross
reacts with bovine 133 kDa iNOS.
consistently and significantly inhibited the spon-
taneous release of NO in OA-affected cartilage, but
showed variable effects (0–30% inhibition at
similar concentrations) in murine macrophages
[27].
OA-affected cartilage spontaneously releases
significant quantities of PGE2 via upregulation of
COX-2 not seen in normal cartilage [22]. We
therefore tested the ability of these NSAIDS to
inhibit spontaneously released PGE2 in OA-af-
fected cartilage in ex vivo assays. As expected,
aspirin (1–3 mm), sodium salicylate (1–3 mm) and
indomethacin (20 mm) significantly inhibited PGE2
production (by q 90%) (Table III).
The effect of dexamethasone was examined on
NO production in OA-affected cartilage explants.
One micromolar of dexamethasone, which signifi-
cantly inhibited PGE2 production, had no signifi-
cant effect on the spontaneous release of NO in the
same explant (Table III).
Tenidap has recently been reported to inhibit
synthesis of various cytokines which include IL-1b
and IL-6 [24]. In three separate experiments
tenidap (at 30 mm) also significantly inhibited the
spontaneous release of NO from OA-affected
cartilage. Tenidap also significantly inhibited the
IL-1b mediated NO production in OA-affected
cartilage (Table IV).
effect of nsaids on inos expressed in rat
chondrosarcoma in ex vivo conditions
The rat chondrosarcoma when maintained in
rats (in vivo) shows upregulation of iNOS
expression and spontaneously releases NO in
ex vivo conditions in the absence of any stimulus
OA-affected cartilage could be inhibited with
pharmacological relevant concentrations of as-
pirin, sodium salicylate, but not indomethacin. The
NOS competitive inhibitor (L-NMA) blocked NO
release in both experiments. These results (with
respect to the effects of aspirin and indomethacin)
were similar to those previously seen with murine
macrophages stimulated with LPS in the presence
of NSAIDS [27]. Sodium salicylate (at 2-3 mm)
Table I
Effect of aspirin and sodium salicylate on spontaneous release of nitric
oxide from OA-affected cartilage in ex vivo conditions
mm nitrite/100 mg Cartilage
Conditions 24 h 48 h 72 h
Control 4.7 2 1.5 10.1 2 1.6 12.9 2 1.2
+ L-NMA (500 mm) 0.9 2 0.5b 0.7 2 0.3a 3.8 2 1.3a
+ Aspirin (1 mm) 2.6 2 0.1c 2.6 2 0.2a 8.5 2 2.0c
+ Aspirin (2mm) 2.7 2 1.1c 4.2 2 0.4a 7.5 2 2.6b
+ Aspirin (3 mm) 2.6 2 1.5c 3.4 2 1.5a 5.2 2 0.9a
+ Aspirin (5 mm) 1.8 2 0.0b 2.6 2 0.2a 3.5 2 0.4a
+ Sodium salicylate (2 mm) 6.8 2 4.9d 7.9 2 4.0c 10.3 2 4.9d
+ Sodium salicylate (3 mm) 3.4 2 0.3c 6.4 2 0.4c 8.2 2 1.9b
OA!affected cartilage from patients undergoing knee replacement surgery was
incubated in medium with various NSAIDS and NOS inhibitor[ Nitrite levels were
estimated as described in Methods[ Data represent mean 2 S[D[ value[ The P!values
described are compared with control unstimulated OA!cartilage[ The data represents one
of the three similar experiments[ "P!values a R 9[9990\ b R 9[990\ c R 9[90\ d R 9[0#[
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Table II
Effect of NSAIDS on spontaneous release of nitric oxide by OA-affected
cartilage in ex vivo conditions
mm nitrite/100 mg Cartilage
Conditions Experiment I Experiment II
Control 6.2 2 2.6 28.3 2 12.7
+ L-NMA (500 mm) ND 3.9 2 2.7a
+ Aspirin (2 mm) 3.3 2 0.7b 7.1 2 4.2b
+ Aspirin (3 mm) 1.6 2 0.5a ND
+ Sodium salicylate (2 mm) 2.5 2 0.5b 21.8 2 17.2c
+ Sodium salicylate (3 mm) 2.6 2 0.4b ND
+ Indomethacin (5 mm) 5.2 2 1.3c ND
+ Indomethacin (20 mm) ND 28.6 2 16.7c
OA!affected cartilage was taken from patients undergoing knee replacement surgery
and incubated in medium for 37 h[ Experiments I and II represent OA!affected cartilage
obtained from two separate patients[ Nitrite levels were estimated as described in
Methods[ Data represent mean2 S[D[ value[ The P!values described are compared with
control "unstimulated# OA!affected cartilage[ NDnot done[ The data represents two
similar experiments[ "P!values a R 9[990\ b R 9[90\ c R 9[4#[
[26] (Table V). L-NMA significantly inhibits the
spontaneous release of NO in ex vivo conditions.
Rat chondrosarcoma cells were exposed to
various NSAIDS in ex vivo conditions to examine
their effects on NO production. Aspirin and
sodium salicylate, but not indomethacin, signifi-
cantly inhibited (in a time- and dose-dependent
manner) the release of NO from the rat chondro-
sarcoma cells cultured in ex vivo conditions. In
contrast, hydrocortisone (at 1 mm) did not inhibit
the NO production in chondrosarcoma cells.
effect of nsaids on bovine chondrocytes
stimulated with cytokine + endotoxins in in
vitro conditions
We examined the expression of iNOS in
bovine chondrocytes stimulated with cytokine +
endotoxin. Bovine chondrocytes and murine
macrophages expressed a 133 kDa iNOS as shown
in Fig. 1. Bovine chondrocytes grown in monolayer
for 48 h were stimulated with IL-1b + TNFa + LPS
in the presence and absence of NSAIDS, and the
levels of NO and PGE2 accumulated in the medium
were examined at different time intervals. Aspirin,
sodium salicylate, and tenidap, but not in-
domethacin or hydrocortisone, significantly inhib-
ited the accumulation of NO in the medium (Table
VI). The concentration of indomethacin and
hydrocortisone was sufficient to inhibit PGE2
production in these cells at 72 h.
Discussion
Our experiments indicate that selected anti-
inflammatory drugs, including the salicylates and
Table III
Regulation of nitric oxide and PGE2 in OA-affected cartilage in the
presence of NSAIDS
per 100 mg Cartilage
Conditions mm Nitrite PGE2 ng/ml
Control 6.2 2 2.6 58.2 2 12.0
+ Aspirin (2 mm) 3.3 2 0.7b 0.2 2 0.1a
+ Aspirin (3 mm) 1.6 2 0.5c 1.6 2 0.1a
+ Sodium Salicylate (2 mm) 2.5 2 0.5c 5.1 + 0.6a
+ Sodium Salicylate (3 mm) 2.6 2 0.4c 4.6 2 1.1a
+ Indomethacin (5 mm) 5.2 2 1.3d 1.3 2 0.1a
+ Dexamethasone (0.1 mm) 7.1 2 1.4d 2.9 2 0.6a
+ Dexamethasone (1.0 mm) 6.5 2 0.9d 4.1 2 0.2a
OA!affected cartilage from patients undergoing knee replacement surgery were
incubated in the medium with various NSAIDS[ The nitrite and PGE1 levels were
estimated from the same experiment as described in Methods[ Data represents
mean2 S[D[ value[ The P!values described are compared with control unstimulated
OA!affected[ The data represents one of the two similar experiments[ "P!values
a R 9[9990\ b R 9[990\ c R 9[90\ d R 9[4#[
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Table IV
Effect of tenidap on nitric oxide production in OA-affected cartilage in ex vivo condition
mm nitrite/100 mg cartilage
Experiment I Experiment II Experiment III
Conditions 24 h 48 h 72 h 48 h 72 h 24 h
Control 1.7 2 0.3 4.2 2 0.6 4.7 2 0.8 2.9 2 1.2 3.1 2 1.4 2.1 2 0.3
+ Tenidap (30 mm) 1.2 2 0.2b 2.1 2 1.2b 2.3 2 1.4b Q 0.1a Q 0.1a 1.4 2 0.2d
+ IL-1 (5 ng/ml) 6.1 2 1.5a 13.4 2 2.5a 16.4 2 3.9a 6.4 2 1.6a 9.4 2 1.4a 3.6 2 0.8b
+ IL-1 + Tenidap (30 mm)* 4.6 2 0.5c 9.2 2 0.7b 10.9 2 0.5b 2.8 2 0.8a 4.6 2 1.4a ND
+ Aspirin (2 mm) ND ND ND 0.2 2 0.3a 0.1 2 0.2a ND
+ IL-1 + Aspirin (2 mm)* ND ND ND 2.3 2 0.2a 2.4 2 0.3a ND
OA!affected cartilage was taken from patients undergoing knee replacement surgery and incubated in medium for 37 h[ Nitrite levels were
estimated as described in Methods[ Experiment I\ II\ III represent OA!affected cartilage obtained from different patients[ Data represent
mean2 S[D[ value[ The P!value described a R 9[990\ b R 9[90\ c R 9[94\ d R 9[0# are compared with control "unstimulated# OA!affected cartilage[
The  "IL!0btenidap:Aspirin# are compared with the IL!0b stimulated OA!affected cartilage[ ND] not done[
tenidap, inhibit NO production by chondrocytes of
three species: human, rats and bovine (Table VII).
This effect is not due to the shared capacity of
these drugs to inhibit COX-2 dependent prosta-
glandin production in these cells, since neither
indomethacin nor glucocorticoids (at concen-
trations sufficient to inhibit PGE2 production)
inhibited NO release. This particular observation
is in contrast with the capacity of glucocorticoid
to inhibit iNOS expression in variety of other
cell types (e.g., macrophages, hepatocytes, and
mesangial cells) across species [28–31]. These
results suggest that the beneficial effects of
glucocorticoids seen in arthritis may not
involve the modulation of NO in cartilage and
chondrocytes.
The current data is consistent with previous
results which indicate that NSAIDS, particularly
the salicylates, exert diverse ‘prostaglandin-inde-
pendent’ effects which may contribute to their
anti-inflammatory properties [16, 32]. Recently,
effects of currently available anti-inflammatory
drugs on nitric oxide production have emerged as
an additional property of these agents. For
example, we have reported [27] that salicylates, but
not indomethacin, inhibit NO production in
LPS-stimulated murine macrophages. In those
studies, aspirin consistently inhibited the ex-
pression of iNOS protein, whereas the effects of
sodium salicylate on iNOS expression was more
variable. In addition, aspirin, but not sodium
salicylate, inhibited the specific activity of iNOS in
cell free extracts, most probably due to the direct
acetylation of iNOS by aspirin [27]. These data are
consistent with those of Aeberhard, et al. [33], and
Kepka-Lenhart, et al. [34] who have reported that
Table V
Effect of NSAIDS on the spontaneous production of nitric oxide by rat chondrosarcoma
cells in ex vivo conditions
mm nitrite
Conditions 16 h 24 h 48 h 72 h
Control 11.7 2 1.3 12.9 2 1.4 18.7 2 1.6 19.4 2 1.5
+ L-NMA (500 mm) 3.2 2 0.4a 3.3 2 0.5a 6.5 2 0.8a 7.1 2 0.9a
+ Aspirin (1 mm) 10.4 2 0.4c 11.3 2 3.6c 15.4 2 0.3a 14.8 2 0.1a
+ Aspirin (2 mm) 9.4 2 0.4b 9.1 2 0.6b 11.8 2 0.7a 11.7 2 0.7a
+ Aspirin (3 mm) 7.1 2 0.6a 6.4 2 0.6a 7.8 2 0.7a 7.9 2 0.8a
+ Sodium salicylate (1 mm) 9.4 2 1.4c 9.9 2 1.1c 14.0 2 1.5d 15.1 2 1.5b
+ Sodium salicylate (2 mm) 7.9 2 0.5a 8.3 2 0.6a 11.2 2 0.6a 11.1 2 0.6a
+ Sodium salicylate (3 mm) 6.0 2 0.5a 6.0 2 0.3a 8.0 2 0.4a 7.9 2 0.4a
+ Indomethacin (20 mm) 12.6 2 0.4e 13.8 2 0.8e 20.7 2 0.8e 21.9 2 0.7e
+ Hydrocortisone (10 mm) 11.9 2 0.3e 12.9 2 0.3e 19.0 2 0.4e 21.3 2 0.4e
Rat chondrosarcoma cells spontaneously release NO in ex vivo conditions\ were incubated with various
NSAIDS and NOS modulators at different concentrations at the time of seeding the cells in the medium[
Nitrite levels were estimated as described in Methods[ Data represent "one of the two similar expts[#
mean2 S[D[ N3[ The P!values described are compared with control cells devoid of any modulators[
"P!value a R 9[9990\ b R 9[990\ c R 9[90\ d R 9[0\ e R 9[4#[
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both aspirin and sodium salicylate (20 mm) inhib-
ited NO production and expression of iNOS
protein in murine macrophages. As was the case in
our prior studies [27], these investigators observed
that salicylates decreased iNOS protein without
inhibiting the amount of iNOS mRNA. The
observation that salicylates inhibit NO production
at a translational step, but not at a transcriptional
step, was confirmed in hepatocytes [35]. Finally,
other investigators have also demonstrated that
the capacity to inhibit NOS is not a property
common to all NSAIDS. In rat cardiac fibroblasts,
for example, aspirin and sodium salicylate, but not
indomethacin or acetaminophen, inhibited cy-
tokine-induced nitrite accumulation in a time and
dose-dependent manner (IC50 0 1 mm) [36]. Thus,
the consistent finding in the literature is that
salicylates, but typically not indomethacin, inhibit
NO production in a variety of cell types, including
chondrocytes, macrophages, hepatocytes and fibro-
blasts, most likely via effects on translation. Our
observation that tenidap is also an effective
inhibitor of NO production, indicates that this is
not a property of salicylates alone, and may be
shared by other classes of anti-inflammatory
agents. Our results have shown that intra-articular
IL-1b produced by OA-affected chondrocytes up-
regulates endogenous NO production which can be
blocked by type I soluble IL-1bR (but not soluble
TNFaR). Spontaneous production of NO by OA
cartilage can also be blocked by cytokine
suppressive anti-inflammatory drugs: CSAID
which inhibit p38 kinase [37]. Our current
experiments also demonstrate that Tenidap, which
is known to inhibit PGE2 production [38], and
synthesis of IL-1b and IL-6 [24] also inhibits
another pleiotropic inflammatory molecule: NO.
The possibility that the inhibition of NO pro-
duction by tenidap is due to the inhibition of the
expression of IL-1b cannot be ruled out by our
experiments.
It should be noted that aspirin which inhibits the
spontaneous release of NO in OA-affected carti-
lage, like tenidap, also blocked the IL-1b induced
NO production in OA-affected cartilage. This is
not surprising because previous studies have
shown that aspirin in murine macrophages block
NOS expression at the translational level and
probably also directly at the enzyme level by
acetylating the enzyme to render it inactive [27].
What are the implications of these observations
that salicylates and tenidap, but not indomethacin,
inhibit NO production by chondrocytes, particu-
larly that produced by OA cartilage? Differences
among currently available anti-inflammatory
agents with regard to NOS inhibition may be
important since several studies have shown that
inhibition of excess NO production in cartilage
may have a ‘chondroprotective role’ [10–13].
However, a full appreciation of the implications of
these findings will only be possible when the
precise role of both NO and PGE2 in cartilage
homeostasis and arthritis is clearly elucidated. In
animal models of arthritis, inhibitors of either
NOS or COX-2 can independently repress joint
inflammation, concomitant with the attenuation of
PGE2 or NO synthesis [3, 4, 39]. In general, the
effects of NO on cartilage are believed to decrease
collagen synthesis [10]; NO has also been impli-
cated in promoting chondrocyte apoptosis [13].
PGE2 is also believed to exert predominantly
injurious effects known to exacerbate joint
inflammation [40], induce IL-1b expression [41] and
promote metalloproteinase production [42–45].
However, PGE2 has also been reported to increase
proteoglycan synthesis, suggesting a possible
reparative role in cartilage [46]. It should be noted
that NSAIDS (unlike the NOS inhibitor: L-NMA)
inhibited both NO and PGE2 production in each of
the chondrocyte systems that we assessed. Further-
more, (unlike NSAIDS) L-NMA augmented PGE2
production in OA-affected cartilage [22] and
bovine chondrocytes stimulated in vitro. Such
studies underscore the complexity of the regu-
lation of NOS and COX-2 in tissues, and indicate
that the pharmacological interference with one
pathway may yield unanticipated effects upon the
other. Taken together, these studies do indicate
that drugs exhibiting selectivity towards both
NOS and COX-2 may offer the potential for
developing novel anti-inflammatory therapies with
the potential to prevent progressive cartilage
deterioration.
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